Qiagen, Biotype Dx Form Joint Venture to Develop MDx Workflows | GenomeWeb

NEW YORK (GenomeWeb) – Qiagen and Biotype Diagnostics today announced a joint venture establishing Biotype Innovation to develop and commercialize molecular diagnostic workflows. 

The workflows to be developed will be initially for personalized healthcare applications based on Qiagen's ModaPlex platform for detecting, characterizing, and measuring up to 100 parameters cost effectively and rapidly. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.